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As self-renewing hematopoietic stem cells (HSCs) are not only a requisite for sustained normal blood cell production but also of critical importance for rapid and sustained reconstitution after bone marrow (BM) transplantation, identification and clinical exploitation of the stem cell self-renewal machinery have been a longsought goal of HSC research (Sorrentino 2004) . HSCs cycle and expand extensively during fetal development and following transplantation (Pawliuk et al. 1996 ; Iscove and Nawa 1997), providing compelling evidence for a positive and dynamic regulation of HSC self-renewal. However, from early postnatal life the HSC compartment is sustained at a relatively constant level (Morrison et al. 1996) . This tight restriction on postnatal HSC expansion, potentially reflecting the enhanced propensity of HSCs to undergo leukemic transformation (Reya et al. 2001) , implicates either the coexistence of important negative regulators of HSC self-renewal, or down-regulation of positive regulators in steady-state hematopoiesis.
Although HSCs represent the best characterized somatic stem cells, the physiological regulators of HSC self-renewal and expansion remain largely unknown. However, a few intrinsic cues-including the transcriptional repressor BMI-1 (Molofsky et al. 2003; Iwama et al. 2004) , the proto-oncogene MYC (Wilson et al. 2004) , and the transcription factor C/EBP␣ (Zhang et al. 2004 )-have, through lack-of-function studies, been implicated as regulators of HSC self-renewal. Further, overexpression of HoxB4 (Antonchuk et al. 2002) promotes extensive HSC expansion ex vivo, although evidence for its physiological role in HSC regulation is lacking.
Whereas the important role of hematopoietic cytokines as extracellular regulators of blood lineage development is indisputably established (Ogawa 1993) , efforts to identify their expected roles as positive regulators of HSC self-renewal and expansion have been disappointing (Sauvageau et al. 2004; Sorrentino 2004; Jacobsen 2005) . Despite more than two decades of exhaustive attempts to promote ex vivo HSC expansion using HSCstimulating cytokines, most efforts have rather resulted in HSC loss, and only in a few cases has limited HSC expansion been achieved (Miller and Eaves 1997; Zhang and Lodish 2005) . Consequently, the enthusiasm to utilize cytokines for HSC ex vivo expansion has waned, and whether cytokines play any role in regulating HSC expansion under physiological conditions has increasingly been questioned (Sauvageau et al. 2004; Jacobsen 2005) . In fact, of all cytokines investigated, only genetic deficiencies in Thrombopoietin (Thpo) or its receptor Mpl result in reduced levels of HSCs (Kimura et al. 1998; Solar et al. 1998) . As THPO efficiently suppresses apoptosis (Pestina et al. 2001 ) and promotes survival of HSCs (Borge et al. 1996) , it has been suggested that THPO may act primarily to counteract HSC apoptosis, rather than promoting HSC expansion.
Recently, mice deficient in expression of Lnk, a member of the APS family of adaptor proteins (Yokouchi et al. 1997) , were demonstrated to have a variety of hematopoietic phenotypes, including an expansion of the HSC compartment (Takaki et al. 2000; Ema et al. 2005) . However, the dynamics of this expansion and the mechanism of action by which LNK might restrict HSC expansion in steady-state hematopoiesis remain unclear, as LNK acts as a broad inhibitor of growth factor and cytokine signaling pathways, including those of THPO, Kit ligand (KITL), Erythropoietin (EPO), Interleukin (IL)-3, and IL-7 (Takaki et al. 2000 (Takaki et al. , 2002 Velazquez et al. 2002; Tong and Lodish 2004; Tong et al. 2005) .
The present studies were designed to identify whether LNK might act as a physiological negative regulator of cytokine-induced HSC expansion, and if so what specific cytokine signaling pathway it might directly target. Herein we provide compelling evidence for LNK being a physiological negative regulator of THPO-induced postnatal expansion of self-renewing HSCs and myeloid progenitors, identifying a unique balance between opposing regulators of cytokine receptor signaling in regulating the size of the HSC and progenitor compartments.
Results and Discussion

Selective and age-dependent expansion of long-term HSCs in Lnk −/− mice
Although previous studies had established that the HSC compartment is expanded in adult Lnk −/− mice (Takaki et al. 2002; Ema et al. 2005) , the role of LNK in regulating recently identified phenotypically and functionally distinct subclasses of HSCs (Fig. 1A,B) . The seeming discrepancy between our finding of expanded LSKFLT3 − cells and no expansion of LSKCD34 − cells in early development reported by Ema et al. (2005) is most likely explained by HSCs not having a LSKCD34 − but rather a LSKCD34 + phenotype in early development (Ito et al. 2000) , whereas HSCs are LSKFLT3 − throughout development (Adolfsson et al. 2001; Christensen and Weissman 2001; L. Yang and S.E.W. Jacobsen, unpubl.) . Thus, in contrast to previously published findings, our data suggest that LNK is already a negative regulator of the extensive physiological HSC expansion that takes place during this stage of fetal development (Pawliuk et al. 1996) . Importantly, the expansion of Lnk −/− LSKFLT3 − cells gradually increased with age, so that the numbers of Lnk −/− LSKFLT3 − cells were increased relative to wildtype mice by 3.2-fold, 4.8-fold, and 8.8-fold in 2-wk-old, 15-wk-old, and 25-wk-old mice, respectively (Fig. 1A,B) . Whereas LSKFLT3 − cells contain pluripotent HSCs, LSKFLT3 + cells are predominantly lymphoid-primed multipotent progenitors (LMPPs) . In striking contrast to the large expansions of LSKFLT3 − cells, the LSKFLT3 + compartment was only increased 1.3-to 2.7-fold in FL or adult BM (Fig. 1B) .
In − cells were increased much less (4.1-fold and 6.3-fold, p < 0.001 and 0.01, respectively, compared with wild type). As shown in wild-type mice , we also found that all long-term multilineage repopulating activity was restricted to the LSKCD34 −
FLT3
− compartment in adult Lnk −/− mice (N. Buza-Vidas and S.E.W. Jacobsen, unpubl.).
We next sought to verify the expansion of LT-HSCs by functional assessment. Thus, limiting dose long-term competitive transplantation assays were performed with wild-type and Lnk −/− FL cells or adult BM cells, along with a standard competitor dose of 2 × 10 5 BM cells . In recipients of FL cells, 17 of 26 (65%) recipients of 20,000 wild-type cells and 12 of 26 (46%) recipients of 7000 Lnk −/− cells showed sustained multilineage reconstitution (Fig. 1D ). This translates into a 1.7-fold increase in the frequency of LT-HSCs in Lnk (Ema et al. 2005) . However, this enhanced potential for serial reconstitution appears rather limited when compared with the extensive HSC expansion in Lnk −/− mice observed postnatally, when expansion of HSCs is normally restricted. This, together with the rather limited increase in fetal expansion of HSCs in Lnk −/− mice, suggests that the role of LNK might primarily be to limit HSC expansion during steady-state hematopoiesis, and that other, LNK-independent, mechanisms might be primarily responsible for promoting the extensive HSC expansion observed during fetal development and post-transplantation (Pawliuk et al. 1996) .
At variance with previous studies (Ema et al. 2005 ), BrdU incorporation experiments suggested that the cycling of adult LT-HSCs is not enhanced in Lnk −/− mice ( Supplementary Fig. 2 ). Interestingly, this suggests that the ability of LNK to suppress postnatal expansion of HSCs is not coupled to regulation over the extent of HSC proliferation. Importantly, leukemia was never observed in Lnk −/− mice or in primary or secondary recipients of Lnk −/− BM cells (N. Buza-Vidas, J. Antonchuk, and S.E.W. Jacobsen, unpubl.).
Thus, Lnk −/− mice have a selective and age-progressive expansion of the minor LT-HSC compartment, identifying LNK as a unique negative regulator selectively targeting LT-HSCs.
Expansion of LT-HSCs in Lnk −/− mice is dependent on thrombopoietin signaling
LNK has been demonstrated to directly inhibit a number of signaling pathways (Takaki et al. 2002; Velazquez et al. 2002; Tong and Lodish 2004; Tong et al. 2005) , and of these the KIT and THPO pathways have been implicated as potential regulators of HSC numbers and/or function (Miller et al. 1996; Kimura et al. 1998; Solar et al. 1998) . As previous studies had failed to couple increased HSC numbers in Lnk −/− mice to enhanced KIT function (Takaki et al. 2002; Ema et al. 2005) , we sought here to establish whether LNK-induced inhibition of HSC expansion might depend on THPO signaling.
Whereas the expression of Bmi-1 and HoxB4 as determined by Q-PCR analysis was virtually unaffected in Lnk −/− LSKCD34 − FLT3 − cells, Mpl expression was slightly increased (1.6-fold) ( Fig. 2A) . Notably, the in vitro THPO proliferative responsiveness of single Lnk
− cells was enhanced both with regard to the number (2.5-fold) and size (6.3-fold) of the clones formed (Fig. 2B) hi cells (Fig. 2C) . The above findings, combined with the documented ability of LNK to directly inhibit THPO-induced signaling (Tong and Lodish 2004) (Fig. 3A,B) . Limiting dilution transplantation experiments-where positively reconstituted mice were defined as having at least 0.1% donor-derived total blood cells and 0. Thpo −/− mice. Similar differences were observed when setting the threshold values for total and lineage reconstitution at a higher level (1.0% and 0.05%, respectively) ( Supplementary Fig. 3) .
Thus, the phenotypic and functional evaluations of HSC numbers demonstrate that the expansion of HSCs in Lnk −/− mice is largely THPO-dependent, supporting that LNK restricts LT-HSC expansion at least in part through inhibiting THPO-stimulated HSC expansion. (Fig. 3A,B) . 
cells in Lnk
−/− mice did not appear to involve THPO signaling (Fig. 3A,B ), in agreement with the inability of LMPPs to respond to THPO, and implicating LNK targeting of other pathways in LMPPs.
The expression of Lnk in HSCs, the enhanced THPO responsiveness of purified Lnk −/− HSCs, and the HSC phenotype in Lnk −/− mice reflecting the restricted pattern of MPL expression on HSCs all support a cell-autonomous increase in HSC numbers in Lnk −/− mice. To further investigate this, we compared reconstitution levels of wild-type BM cells transplanted into lethally irradiated wild-type and Lnk −/− recipients ( Supplementary  Fig. 4 ). As long-term multilineage reconstitution was in fact slightly lower in Lnk −/− than wild-type recipients, these findings support that the expansion of HSCs in Lnk −/− mice is due to an intrinsic loss of LNK function in LT-HSCs.
LNK inhibits THPO-dependent expansion of colonyforming unit-spleen (CFU-S) and myelo-erythroid progenitors
We next explored to what degree the reported increases of myeloid and B lymphoid progenitors in Lnk −/− mice (Velazquez et al. 2002) and corresponding decrease of myeloid progenitors in Thpo −/− mice (Carver-Moore et al. 1996) could also reflect LNK-mediated inhibition of THPO-dependent expansion of committed myeloid progenitors.
The CFU-S assay detects multipotent myelo-erythroid progenitors with limited self-renewal ability (Till and McCulloch 1961) . Adult Lnk −/− mice had a 2.6-fold expansion of day 12 CFU-S, whereas these were decreased to 18% of wild type in Thpo −/− mice (Fig. 4A) . As CFU-S numbers were comparable in Thpo −/− and Lnk
mice, the CFU-S expansion observed in Lnk −/− mice also proved to be strictly dependent on THPO signaling.
Committed granulocyte-macrophage (CFU-GM) (Fig.  4B) , erythroid (BFU-E) (Fig. 4C) , and megakaryocyte (CFU-Mk) (Fig. 4D) progenitors were all increased in Lnk −/− mice and reduced in Thpo −/− mice, and, similar to CFU-S, their increase in Lnk −/− mice was entirely THPO-dependent.
In agreement with previous studies (Takaki et al. 2000; Velazquez et al. 2002) , we also found early B220 + IgM − B cells to be expanded in the BM of Lnk −/− mice, but, in contrast to myeloid progenitors, this expansion was entirely THPO-independent (Fig. 4E ), in agreement with B cells being unaffected in Thpo −/− mice . The coupling of LNK and THPO as opposing regulators of myeloid but not lymphoid lineage development was also evident in peripheral blood (PB) ( Table 1) , as the increase in PB lymphocytes in Lnk −/− mice was THPOindependent, whereas the increases in neutrophils, monocytes, eosinophils, and platelets were all THPOdependent.
In conclusion, these studies demonstrate that Lnk These studies demonstrate, for the first time, the importance of interaction between positive and negative regulators of cytokine signaling in controlling HSC expansion. The findings demonstrate that THPO, under physiological conditions in steady-state adult hematopoiesis, not only promotes HSC survival as previously suggested, but also stimulates HSC expansion, the extent of which is tightly restricted through the ability of LNK to negatively regulate THPO signaling. The possibility of specifically targeting these potent stimulatory and inhibitory pathways for HSC expansion should trigger renewed interest and efforts toward exploitation of cytokine pathways to promote ex vivo HSC expansion for therapeutic purposes.
Materials and methods
Mice
The Lnk −/− mouse strain was generated as previously described (Takaki et al. 2000) , and the Thpo −/− strain was generated by Dr. F. de Sauvage at Genentech, Inc. (San Francisco, CA) . Both strains were backcrossed to C57Bl/6 mice for >10 generations. Lnk −/− mice were mated to Thpo −/− to generate Lnk −/− Thpo −/− mice. C57Bl/6 wild-type mice were used as controls. All animal protocols were approved by the local ethics committee at Lund University. 
Isolation of hematopoietic cells and fluorescence-activated cell sorting (FACS) analysis of LIN
Competitive repopulation assay
The competitive repopulation assay using the congenic CD45.1/CD45.2 mouse model has been described previously (Szilvassy et al. 1990; Yang et al. 2005 hi BM cells were seeded into individual wells of Terasaki plates in 20 µL serum-free medium (X-vivo15; BioWhittaker), supplemented with 1% bovine serum albumin (StemCell Technologies, Inc.) and 50 ng/mL human THPO for 10 d, at which time wells were scored for clonal growth as previously described . CFU-GM, BFU-E, and CFU-Mk in unfractionated BM cells were evaluated in methylcellulose cultures as previously described . For more detailed information, see the Supplemental Material. −/− mice were subjected to Q-PCR analysis as recently described . Assays-onDemand probes (InVitrogen) used were HPRT Mm00446968_m1, Lnk Mm00493156_m1, Mpl Mm00440310_m1, Hoxb4 Mm00657964_m1, and Bmi-1 Mm00776122_gH. All experiments were performed in triplicate and differences in cDNA input were compensated by normalization against HPRT expression levels. 
Q-PCR
CFU-S
Thpo
−/− mice were transplanted into lethally irradiated wild-type recipients, and 12 d after transplantation macroscopic colonies were evaluated after fixation of spleens in Tellesnicky's fixative, as previously described .
Peripheral blood cell analysis PB was collected from the retro-orbital sinus into EDTA-coated tubes (Sarstedt) and analyzed in an automated cell counter (Sysmex). Differential counts were also obtained by microscopic examination of May-Grün-wald/Giemsa-stained PB smears. 
